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SurvivinHepatocytes in primary culture undergo apoptosis upon exposure to glycochenodeoxycholate (GCDC). The
signaling mechanisms of GCDC-induced apoptosis remain unclear. To investigate the role of antiapoptotic
genes, we compared apoptotic response in primary hepatocytes following GCDC treatment. The hepatocytes
from adult Sprague–Dawley rats were cultured in collagen-coated dishes and treated with GCDC in varying
concentrations, or the same concentration at different time intervals. Apoptosis was detected by the terminal
deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay, DNA fragmentation assay,
and caspase assays. Expression of apoptosis-related genes and proteins was evaluated by RT-PCR,
quantitative real-time PCR (qRT-PCR), and Western blotting, respectively. The DNA-binding property of a
nuclear protein was assessed by electrophoretic mobility shift assay (EMSA) and chromatin immunopre-
cipitation (ChIP) assay. An interesting result was that GCDC caused hepatocyte apoptosis to display a
biphasic phenomenon at a dosage of 50 μM, whereas it was not found at higher dosages such as 200 μM.
GCDC stimulated the expression of antiapoptotic Survivin, which also presented a biphasic response. The
activation of nuclear factor-kappaB (NF-κB) corresponded with the up-regulation of Survivin. The inhibitor
of NF-κB, BAY 11-7082, suppressed the expression of Survivin and simultaneously eliminated the biphasic
response. The expression of Survivin was transcriptionally mediated by the activation of NF-κB, as shown by
EMSA and ChIP assay. Conclusions: These results demonstrated that a low dosage of GCDC induced the
hepatocyte apoptosis to exhibit the biphasic response, which was regulated by the expression of Survivin
through NF-κB signaling pathway.-κB, nuclear factor kappa B;
cellular inhibitor of apoptosis
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Glycochenodeoxycholate (GCDC) is synthesized in the liver through
conjugating glycine with chenodeoxycholic acid. Intracellular retention
of cytotoxic GCDC contributes to apoptosis in hepatocytes [1–3]. GCDC
induces hepatocyte apoptosis through both death-receptor pathway
and themitochondrial pathway [4,5]. Some pathways such as Fas death
receptor, TRAIL-Receptor 2/DR5, protein kinase C, activation of
cathepsin B, have been investigated [6,7]. Fas receptor ligation activates
procaspase-8, which either directly causes activation of caspase-3 to
induce apoptotic cascade or in turn cleaves the bcl-2 family protein, bid,
to a truncated form that translocates to mitochondria and initiates
mitochondrial pathways through activation of downstream effectorcaspases [8,9]. In addition, GCDC induces hepatocyte apoptosis through
Fas-independent mechanisms which could be demonstrated by the
increased expression of TRAIL-R2/DR5 in HuH-7 cells (Fas deﬁcient)
with GCDC treatment. Mitochondrial cytochrome c release and
apoptosis are inhibited by transfection with dominant negative FADD
constructs, or treatment with the selective caspase-8 inhibitor [10].
Bile acids induce apoptosis of hepatocytes through oxidative stress
and mitochondrial dysfunction in vitro [8]. Generation of reactive
oxygen species, induction ofmitochondrial permeability transition, and
release of cytochrome c are critical steps in the induction of apoptosis by
bile acids. GCDC-induced apoptosis was associated with lipid peroxida-
tion as demonstrated by an increase in 8-isoprostane release.
Antioxidants inhibited both lipid peroxidation and apoptosis [1].
Antioxidants reduced bile acid-induced liver injury through preventing
the generation of oxidant stress, subsequent stimulation of the
mitochondrial permeability transition, and release of cytochrome c
from mitochondria [8]. In vivo cytokines are key mediators within the
complex interplay of intrahepatic immunecells andhepatocytes, as they
can activate effector functions of immune cells as well as hepatocytic
intracellular signaling pathways controlling cellular homeostasis [11].
Kupffer cells and liver-inﬁltratingmonocyte-derivedmacrophagesmay
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prostaglandin E2 [12]. TNFα can activate speciﬁc intracellular pathways
in hepatocytes that inﬂuence cell fate in different manners, e.g.,
proapoptotic signals via the caspase cascade, survival signals through
NF-κBpathway [13]. NF-κB is a key player in the inﬂammatorypathway,
e.g., in cytokine-mediated hepatocyte apoptosis [14].
NF-κB is found in almost all animal cell types and is involved in
cellular responses to stimuli such as stress, cytokines, free radicals,
ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens [15].
NF-κB is a vital regulator for oxidative stresses, which is well known for
its role in inﬂammation, immune response, control of cell division and
apoptosis [16]. The functionofNF-κB isprimarily regulatedby IκB family
members, which ensure cytoplasmic localization of the transcription
factor in the resting state. Upon stimulus-induced IκB degradation, the
NF-κB complexes move to the nucleus and activate NF-κB-dependent
transcription [17]. NF-κB is an oxidative stress responsive transcription
factor and plays a signiﬁcant role in the process of apoptosis [18]. The
activation of NF-κB belongs to intracellular survival pathway in the
context of death-receptor-induced apoptosis in the liver. At present we
partially understand the correlation between NF-κB and anti–apoptotic
genes, such as cIAP1, cIAP2, XIAP, Survivin, A1/Bﬂ-1, and iNOS [19].
NF-κB regulates important functions in cholestatic liver pathology [14].
During obstructive cholestasis, NF-κB is activated in hepatocytes and
functions to reduce liver injury [20]. NF-κB is also required for
hepatocyte proliferation in bile duct ligated mice [21]. Moreover,
NF-κB mediates the upregulation of iNOS that is further augmented by
oxidative stress [22].
In an effort to understand the mechanisms through which GCDC
induces hepatocyte apoptosis, we performed a direct comparison of the
signaling response of caspase, NF-κB, and antiapoptotic genes. Primary
hepatocytes were utilized in this study to pursue the following
objectives: (i) the apoptotic effect of time- and dose-dependent
alterations following GCDC treatment; (ii) the interaction of caspase,
NF-κB, and antiapoptotic genes during GCDC-induced apoptosis. A
striking result was that GCDC not only induced hepatocyte apoptosis,
but also caused a biphasic response under low dosage of 50 μM.
Moreover the biphasic response was correlated to the alteration of
caspase activity, NF-κB activation, and Survivin expression. These
ﬁndings indicate that NF-κB and Survivin are important signal factors
that regulate GCDC-induced apoptosis.
2. Experimental procedures
2.1. Cell culture
Hepatocytes were isolated from adult Sprague–Dawley rats along
the standard liver perfusion procedure [23] and cultured as previously
described [24]. Dead cells were removed by Percoll (Sigma) gradient
centrifugation. Following the last wash, hepatocytes were resuspended
in coldWilliam's E medium, diluted to a density of 5.5×105, and plated
into collagen-coated dishes (Falcon). The cells were incubated at 37 °C
for 6 h before GCDC treatment.
2.2. Caspase assay
Caspase activity was determined from the GCDC-treated hepato-
cytes. 100 μgof cell lysatewasutilized to assay theactivities of caspase-3
or caspase-8. Caspase assay kit was purchased from Calbiochem. The
reaction system employed the colorimetric substrate IETD-pNA and
calculated the activity as pmol/min.
2.3. Reverse transcriptase-polymerase chain reaction (RT-PCR) and
real-time PCR
Total RNA was isolated with ready-to-use TRIZOL Reagent
(Gibco, Invitrogen). RT-PCR kit was obtained from Qiagen. The cDNAproduct was ampliﬁed with Taq DNA polymerase using standard
protocols. The 5′ forward and 3′ reverse complement PCR primers for
Survivin were CTGATTTGGCCCAGTGTTTT and TCATCTGACGTC-
CAGTTTCG, respectively. For cIAP2, PCR primers were ACATTTCCCCAGC
TGCCCATTC and CTCCTGCTCCGTCTGCTCCTCT. For cIAP1, PCR primers
were CCAGCCTGCCCTCAAACCCTCT and GGGTCATCTCCGGGTTCCCAAC.
For XIAP, PCR primers were CGCGAGCGGGGTTTCTCTACAC and ACCAGG-
CACGGTCACAGGGTTC. For A1/Bﬂ-1, PCR primers were ATCCACTC
CCTGGCTGAGAACT and ACATCCAGGCCAATCTGCTCTT. For iNOS, PCR
primers were CGAGGAGGCTGCCTGCAGACTGG and CTGGGAGGAGCT-
GATGGAGTAGTA. All PCR primerswere synthesized from Integrated DNA
Technology. The relativemRNA levels of Survivinwere conﬁrmed by real-
time PCR. The data were normalized to the expression level of 18S rRNA.
2.4. TUNEL assay
TdT-FragEL™ DNA fragmentation detection kit was obtained from
Calbiochem (#QIA33) and tissue slides were prepared according to
instructions. Brieﬂy, slideswere treatedwithproteinaseK (20 μg/mL) in
10 mM Tris–HCl (pH 8.0). Endogenous peroxidase was inactivated by
incubating the sections for 5 min in 3% H2O2 at room temperature. Cells
were incubated in a moisture chamber for 1 h at 37 °C with 3.0 μl TdT
enzyme. The reactionwas stopped by 0.5 MEDTA, detected byDAB, and
counterstained by 0.3% mythyl green.
2.5. Immunoblot analysis
Protein samples weremade from cold RIPA buffer, boiled for 10 min
in Laemli sample buffer, resolved by 10% SDS-polyacrylamide gel
electrophoresis, transferred to nitrocellulose membrane, and blotted
with appropriate primary antibodies at dilution of 1:500–1000.
Peroxidase-conjugated secondary antibodies were incubated at a
dilution of 1:2000–3000. Bound antibody was visualized using
chemiluminescent substrate (ECL; AmershamBiosciences) and exposed
to Kodak X-Omat ﬁlm. At least three independent experiments were
performed.
2.6. Electrophoretic Mobility Shift Assay (EMSA)
Nuclear protein extractswere prepared asdescribedbyDignamet al.
with modiﬁcation [25]. 4 μg of nuclear protein and 2 μg of the
nonspeciﬁc competitor poly(dI·dC) were incubated in binding buffer
(100 mM Hepes, pH 7.6, 5 mM EDTA, 50 mM (NH4)2 S04, 5 mM DTT,
Tween 20, 1% (w/v), 150 mM KCl) with 20 fmol/μl of double-stranded
DNA oligonucleotide containing an NF-κB consensus binding sequence
(5′-AGTTGAGGGGAC TTT CCCAGGC-3′) thatwas labeledwith digoxin
using terminal transferase. For super gel shift, NF-κB p50 antibody
(Santa Cruz sc-7178) was added into an oligonucleotide-protein
complex.
2.7. Chromatin Immunoprecipitation (ChIP) Assays
The liver tissue was homogenized and then ﬁxed at 1% Formalde-
hyde. The ﬁxed liver tissue was resuspended in 2 ml Lysis Buffer (5 mM
PIPES, 85 mM KCl, 0.5% NP-40, Protease Inhibitor Cocktail, pH 8.0). The
crude nuclear extract was re-suspended in Lysis Buffer High Salt
(1×PBS, 1% NP-40, 0.5% Sodium Deoxycholate, 0.1% SDS and Protease
Inhibitor Cocktail), and subsequently sonicated at a power setting of
30%. NF-κB p50 and p65 antibodies (Santa Cruz) were applied for
immunoprecipitation. Crosslinks were reversed by addition of 400 μl
Elution Buffer (1% SDS, 0.1 MNaHCO3) and 0.2 MNaCl overnight. 2 μl of
ChIP DNA was ampliﬁed using a MyiQ Single Color Real-Time PCR
Detection System (Biorad, Carlsbad, CA). The 5′ forward and 3′ reverse
PCR primers were 5′-CGCAGAGCACGTGGGACCTG-3′ and 5′-GGCGAC-
GACTGTAGCGCCTC-3′.
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All data represent at least three experiments using cells, or extracts
from a minimum of three separate isolations and are expressed as
means±SD unless otherwise indicated. Statistical signiﬁcance of
differences is determined using either repeated measures for the
ANOVA followed by Bonferroni correction or Student's t-test for
independent samples. P valuesb0·05 were considered signiﬁcant.
3. Results
3.1. GCDC induced apoptosis in rat hepatocytes with biphasic phenomenon
Rat hepatocytes were cultured inWilliam's E medium containing 10%
FBS and treated with GCDC in different intervals. GCDC could induce
apoptosis with biphasic phenomenon as shown by TUNEL assay
(Fig. 1A, B). Apoptosis began at 2 h after incubating the cells with 50 μM
GCDC. More cells died of apoptosis at 4 h and 14 h. Apoptotic rates were
21% at 4 h and 17% at 14 h, respectively. In addition, GCDC-induced
apoptosis could be reﬂected by caspase activation. Caspases are divided
into two groups, based on their assumed role in the apoptotic cascade.
Long-prodomain caspase-8 and short-prodomain caspase-3 were chosen
toestimate their involvementduringGCDC-inducedhepatocyte apoptosisA B
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Fig. 1. Hepatocytes were exposed to 50 μM of GCDC. (A) TUNEL staining-GCDC treatment f
rate (%). (C) Caspase-8 activity. 100 μg of cell lysates was utilized to measure enzyme activi
(50 μM). The extinction coefﬁcient for p-nitroaniline is 10,500 M−1 cm−1. Results are showed
control. (D) Caspase-3 activity. (E) Activated Casepase-8 protein by immunoblotting. (F) Ac
blot signals over beta-actin expression. (H) Quantitation of Caspase-3 western blot signals[3]. Activities of caspase-3 and caspase-8 were signiﬁcantly elevated
(Fig. 1C, D). The time-course of caspase response showed the kinetic
process of apoptosis in rat hepatocytes. Activities of caspase-3 and
caspase-8 reached the highest levels at 2 h, then reduced gradually, and
increased again at 14 h. A biphasic responsewas observed in the 2 h–14 h
duration at the concentration of 50 μM GCDC. Western blotting further
conﬁrmed the protein expression of caspase-8 and caspase-3 (Fig. 1E, F).
Quantitation ofWestern blots by using β-actin as the loading control was
consistent with that of caspase enzyme kinetics (Fig. 1G, H). GCDC could
induce hepatocyte apoptosis, which showed the biphasic response from
2 h to 14 h at the concentration of 50 μMGCDC.
3.2. The biphasic phenomenon was GCDC dosage-dependent
The biphasic response was found at the concentration of 50 μM
GCDC, but we did not know whether the biphasic response would
change as GCDC dosage was adjusted. Next, the experiments were
designed to measure differences in apoptosis following the varying
concentrations of GCDC. TUNEL assay, histological staining, DNA
fragmentation assay, and caspase assay were utilized to evaluate
apoptosis in rat hepatocytes. In fact, 200 μM of GCDC caused acute
necrosis of primary hepatocytes. Necrotic cells broke into debris or
underwent cell lysis (Fig. 2A, B). Microscopic viewing showed a largeCaspase 3 activity
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previous observation [8,26]. Lactate dehydrogenase (LDH), the most
widely used indicator of cellular necrosis, was signiﬁcantly released in
the treatment of 200 μM GCDC (Fig. 2C). At a concentration of 200 μM
GCDC, DNA fragmentation assay demonstrated that hepatocyte apo-
ptosis beganat 2 h (Fig. 2D). Thereafter, hepatocyte apoptosis decreased
from 4 h to 24 h. Activities of both caspase-3 and caspase-8 were also
increased to the highest level at 2 h and reduced thenceforth with only
one single peak individually (Fig. 2E, F). No biphasic responsewas found
at the concentration of 200 μM GCDC. Clearly, the apoptotic pattern in
hepatocyte was affected by different concentrations of GCDC. GCDC
inducedmore necrosis at higher concentrations (200 μM) of GCDC than
at lower concentrations (25 μM) of GCDC that was associated with the
main apoptosis (data not shown). These data conﬁrmed that the high
concentration of GCDC caused more necrosis than apoptosis in the
primary culture of rat hepatocytes. Thus the biphasic response of GCDC-
induced hepatocyte apoptosis was dose (or concentration)-dependent.
3.3. Expression of antiapoptotic genes following GCDC treatment
After the stimulation by the 50 μM of GCDC, some hepatocytes
survived apoptosis. It could be hypothesized that the up-regulated
antiapoptotic genes accounted for the cell survival. To prove this
hypothesis, total RNA was isolated from cells and RT-PCR or real-time
PCR was performed to determine the levels of antiapoptotic genes.
Since antiapoptotic genes are a big family, we only selected cIAP1,BA
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Through RT-PCR we distinguished no differences among cIAP1, cIAP2,
XIAP, A1/Bﬂ-1 (Fig. 3A), but differences were found in iNOS and
Survivin from 2 h to 14 h. iNOS gene had a high expression at 2 h and
then decreased gradually to the lowest level at 14 h through an
unknownmechanism. Survivin was increased at 4 h, decreased at 6 h,
enhanced at 8 h, and maintained at the same level up to 14 h. The
expression of Survivin showed biphasic response. Furthermore, the
gene expression of Survivin was conﬁrmed by real-time PCR that
showed a similar pattern to RT-PCR (Fig. 3B). By Western blotting,
protein expression of Survivin (Fig. 3C) displayed the same biphasic
pattern as gene expression. The aforementioned data were gathered
from the combination of both cells ﬂoating in medium and cells
attached to the dish. To clarify expression of Survivin from dish-
attached cells, we removed the cells ﬂoating in the medium, isolated
RNA from dish-attached cells, and then re-ran RT-PCR or real-time
PCR (data not shown). The results were exactly consistent, which
means the expression of Survivin came mainly from dish-attached
cells (Fig. 3D). GCDC could up-regulate intracellular, antiapoptotic
Survivin that might modulate hepatocyte apoptosis.
3.4. GCDC stimulated the activation of NF-κB
GCDC induced the activation of NF-κB in the currentmodel (Fig. 4A).
Moreover, the activation of NF-κB generated a biphasic response in the
time-course of 2 h to 14 h, which coincided with the pattern ofC
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Fig. 3. (A) After the stimulation of 50 μMGCDC, the expression of cIAP1, cIAP2, XIAP, Survivin, A1/Bﬂ-1, iNOS, and GAPDH was determined by RT-PCR. (B) Survivin showed biphasic
response as demonstrated by quantitative real-time PCR as well as RT-PCR. (C) By Western blotting, protein level of Survivin displayed the same biphasic pattern as that of gene
expression. (D) The expression of Survivin mainly came from dish-attached cells.
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NF-κB inhibitor (30 μM of BAY 11-7082) was incubated with the
primary hepatocytes, the biphasic activation of NF-κB was eliminated
(Fig. 4B). Considering the expression of biphasic Survivin, it was
speculated that GCDC-induced hepatocyte apoptosis was associated
with the activation of NF-κB. The activated NF-κB further up-regulated
the expression of Survivin. Perhaps because of the up-regulation of
intracellular antiapoptotic Survivin in the G2-M phase hepatocytes,
these cells could survive the GCDC-induced apoptosis. The surviving
cells made a second apoptotic peak at 14 h under continuous treatment
of 50 μM GCDC. NF-κB may be an important regulator that plays a
pivotal role during GCDC-induced hepatocyte apoptosis.
3.5. Expression of Survivin mediated by NF-κB
The biphasic response was associated with NF-κB activation as
well as Survivin expression. However, it was still unclear what theA
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Fig. 4. GCDC stimulated the activation of NF-κB. (A) NF-κB activated by 50 μM of GCDC with
BAY 11-7082.levels of antiapoptotic genes were when NF-κB was inactivated. By
having employed 30 μM of BAY 11-7082 in culture medium for
60 min, hepatocytes were treated with 50 μM of GCDC in different
intervals and then DNA, RNA, cell lysate, and nuclear proteins were
collected. The biphasic activation of NF-κB was not found by gel
mobility shift assay (Fig. 4B). Expression of antiapoptotic genes such
as Survivin, XIAP, A1/Bﬂ-1, and iNOS was down-regulated with the
lapse of incubation time, except iNOS and XIAP were up-regulated at
8 hwith unknown signiﬁcance (Fig. 5A).Western blotting for Survivin
protein presented a similar pattern to its gene expression through
RT-PCR (Fig. 5B). NF-κB inhibitor BAY 11-7082 could eliminate the
biphasic phenomenon, as proven by DNA fragmentation assay
(Fig. 5C). When total RNA was extracted from dish-attached cells,
RT-PCR demonstrated that the antiapoptotic expression of Survivin
was identical to that of the combination of both cells ﬂoating in
medium and cells attached to dish (Fig. 5D, A). Morphological study
by H&E staining and TUNEL assay showed that more apoptosis was2h 4h 6h 8h 14 h G4h Inhibitor
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inhibitor (data not shown). NF-κB inhibitor BAY 11-7082 down-
regulated the expression of antiapoptotic Survivin and eliminated the
biphasic response of hepatocyte apoptosis at the concentration of
50 μM GCDC. NF-κB may have protected hepatocytes from apoptosis
through the up-regulation of Survivin.
3.6. NF-κB was the transcriptional factor regulating the expression of
Survivin
During GCDC-induced apoptosis in primary hepatocytes, NF-κB is
activated at the same time. The activation of NF-κB may be a protective
response although the exactmechanism is still under investigation [24].
In rat there are two potential binding sites of NF-κB in the Survivin
promoter region, which are at−197 (site 1: GGGACTTTCC) and−149
(site 2: TTTCCAGAGG) upstreamof the ATG initiator codon respectively.
Moreover the site 2 is highly conserved in mouse Survivin promoter at
position −158 bp (Fig. 6A). EMSA was carried out to investigate
whether NF-κB nuclear protein could directly bind to Survivin promoter
region, based on the differential mobility of free DNA and DNA protein
complexes in non-denaturing polyacrylamide gel. Oligo probes using
the sequences 5′-CTCATGGGGCGGGACTTTCCCGGCTGACCT-3′ (Oligo 1)
and 5′-AAGGCGACTTTTTCCAGAGGGCGTGGCCTG-3′ (Oligo 2) were
designed, in which the NF-κB binding consensus was underlined. By
EMSA, the two in vitro-synthesized oligo probes could bind nuclear
protein (Fig. 6B). The only difference was the intensity at which oligo
probes can bind the nuclear protein. It appeared that the probe
at −197 bp distal site had a higher afﬁnity for NF-κB nuclear protein
than the one at−149 bp site.When theNF-κBp50 antibody (Santa Cruz
sc-7178) was added into oligo1-protein complex to identify NF-κB
speciﬁc protein through super gel shift, binding of the antibody resulted
in further retardation of the band through the gel (Fig. 6C). Through
EMSA and super gel shift, we demonstrated that there existed DNA
sequences in the Survivin promoter region that can be bound by NF-κB
nuclear protein. In order to ﬁnd direct evidence to conﬁrm therelationship between NF-κB and Survivin, ChIP assay was performed
to study the protein:DNA interactions in their native chromatin context.
Following immunoprecipitated protein:DNA complexes, reversed the
cross-links, and removed proteins, DNA fragmentswere extracted. Then
the isolated DNA was analyzed by using primers designed to amplify a
potential regulatory region. The ratio of NF-κB antibody/IgG was
6.6-fold (P=0.0136). Through combining the data from the EMSA,
super gel shift, and ChIP assay, we concluded that Survivin was
regulated by the NF-κB nuclear protein (Fig. 6D, E).
4. Discussion
Hepatocyte apoptosis, a distinct process of cell death, can be
observed in such conditions as viral infection, alcoholic hepatitis,
cholestatic disorders and so on [27]. GCDC causes hepatocyte apoptosis
that can be reﬂected by morphological markers (e.g. TUNEL assay) and
functional indicators (e.g. caspase assay). TUNEL assay relies on the
presence of nicks in the DNA that can be identiﬁed by terminal
deoxynucleotidyl transferase, an enzyme catalyzes the addition of
dUTPs that are secondarily labeled with a marker [28]. TUNEL assay is a
classical method for detecting DNA fragmentation that results from
apoptotic signaling cascades. During apoptosis, caspases execute the
disassembly of cellular components by proteolytic cleavage of a variety
of substrates. Some of the caspases identify and cleave a speciﬁc peptide
substrate, whereas others recognize the same peptide substrate to
activate caspase cascades [29]. The caspase substrate cleavage causes
the characteristic 'DNA ladder' in apoptotic cells, a key feature of
programmed cell death that can be measured by DNA fragmentation
assay.However, it ismoredifﬁcult to quantifyDNA fragmentation. In the
current study both TUNEL and caspase assayswere utilized as hallmarks
of apoptosis to estimate their involvement during GCDC-induced
hepatocyte apoptosis.
Our data and previous studies have demonstrated that some
hepatocytes were still alive after treatment with 50 μM GCDC, which
means these cells have the intrinsic ability to resist apoptosis [1,30,31].
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Fig. 6. Survivin is transcriptionally regulated by NF-κB. (A) Alignment of Survivin gene promoter between rat and mouse. (B) Two oligonucleotide sequences bearing NF-κB DNA-
binding consensus in rat Survivin promoter. (C) DNA-binding property of NF-κB was assessed by EMSA and super gel shift. NP: Nuclear protein. (D) ChIP assay to access Survivin
promoter occupancy by NF-κB. The ratio of NF-κB Ab/IgG was 6.6-fold (P=0.0136). (E) Combined data from EMSA, super gel shift, and ChIP assay, it is concluded that Survivin is
regulated by NF-κB nuclear protein.
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cIAP2, XIAP, Survivin, A1/Bﬂ-1, and iNOS to study their role during
GCDC-induced apoptosis. There were no signiﬁcant differences among
cIAP1, cIAP2, XIAP, and A1/Bﬂ-1 except Survivin. The up-regulated
Survivin protected the hepatocyte from GCDC-induced apoptosis at a
dosage of 50 μM. If a high dosage (e.g. 200 μM) of GCDC was used,
approximately 70%of the cellswere deadwithin 4 h (Fig. 2). Yerushalmi
et al. found thegenerationof reactiveoxygenspecies playeda signiﬁcant
role in high dosage necrosis [8]. The high dosage of GCDC probably
caused a heavily acute necrosis that prevented the hepatocytes from
ampliﬁcation of anti-apoptotic genes such as Survivin. However in low
dosages (e.g. 50 μM), cells had enough time to adjust anti-apoptotic
levels to adapt to the environment. That might be the reason why the
biphasic response of GCDC-induced apoptosis was only apparent at the
concentration of 50 μM, not 200 μM. Therefore, the biphasic response
was dose-dependent. Survivin might be responsible for the biphasic
response during GCDC-induced hepatocyte apoptosis. This study will
broaden our understanding of the mechanisms of apoptosis and its
modulation, which are crucial factors for the liver injury/repair
response toward the long term goal of designing future hepatoprotec-
tive strategies through potential use of the NF-κB/Survivin signaling
pathway.
Survivin is the smallest member of the inhibitor of apoptosis
protein family, which is expressed in several apoptosis-regulated fetal
tissues, including lung, liver, heart, and gastrointestinal tract [32].
Survivin is a direct inhibitor of caspase-3 [33]. The activation of
Survivin is critically required for suppression of GCDC induced-
hepatocyte apoptosis [24,34]. Moreover Survivin is crucial for mitosis
and cell cycle progression, which plays a signiﬁcant role in the process
of cell proliferation in human cancer [35,36]. Survivin is regulated bythe cell cycle and its expression is found to be dominant only in the
G2/M phase [36]. The biphasic response of hepatocyte apoptosis in
our study may result from the surviving hepatocytes in the G2/M
phase of the cell cycle. The additional evidence for Survivin regulating
apoptosis can be found during angiogenesis [37]. Endothelial cells
receive cues from growth factors to initiate mitosis, migration, and
organization of endothelial cells into primitive angiotubes and patent
vascular networks. Up-regulation of Survivin in endothelial cells
protects endothelium from death-inducing stimuli. Furthermore,
dominant negative Survivin negates the ability of Angiopoietin-1 to
protect cells from undergoing apoptosis [38]. GCDC causes hepatocyte
injury by oxidative stress, in which reactive oxygen species can act as
signaling molecules to up-regulate the expression of Survivin. Up-
regulation of Survivin can suppress apoptosis through two possible
mechanisms. One is that it enables the hepatocytes to adapt to the
GCDC-stressed microenvironment through ampliﬁcation of Survivin-
related genes [39]. This process of adaptation requires about 4 h or
longer in our experimental system. The other is that the ampliﬁed
Survivin directly inhibits activation of caspases since the hepatocytes
in G2/M phase can express Survivin to survive the GCDC-induced
apoptosis. Anyway, all of these speculations require further testing.
NF-κB is a critical regulator for gene expression induced by diverse
stress signals that include themutagenic andoxidative stresses [40]. The
activation of NF-κB is likely to be involved in the induction of gene
expression associated with hepatocyte adaptation [41]. This nuclear
transcription factor appears to function both as a pro- and as an
anti-apoptotic factor depending upon cell type and mode of stress [42].
Our study demonstrates the activation of Survivin plays an important
role for hepatocyte to resist GCDC-induced apoptosis. The involvement
of NF-κB is an essential component of the Survivin signaling pathway.
1375K. Wang et al. / Biochimica et Biophysica Acta 1803 (2010) 1368–1375NF-κB could mediate hepatocyte apoptosis through up-regulation of
Survivin. Our study also documented that NF-κB inhibitor (BAY 11-
7082) could decrease Survivin expression and caused a signiﬁcant
increase in hepatocyte apoptosis. Schoemaker et al. had shown that bile
acids did not activate NF-κB from 30 min to 1 h with 50 μM GCDC [43].
Rather the cytokines-activated NF-κB during cholestasis could protect
hepatocytes against GCDC-induced apoptosis through the pathway of
up-regulating A1/Bﬂ-1 and cIAP2 (4 days and 1, 2, 3 and 4 weeks).With
differences, we harvested cells at 2 h, 4 h, 6 h, 8 h, and 14 h separately.
The time frame was dissimilar from Schoemaker's study. Moreover, we
did not ﬁnd that the expression of both A1/Bﬂ-1 and cIAP2 was
signiﬁcantly up-regulated during 2 h–14 h treatment except Survivin
(Fig. 3). More important, Schoemaker's results originated from in vivo
study by employing Wistar rats subjected to bile duct ligation.
Schoemaker's data had different conditions from our in vitro study.
Thus, a further investigation needs to be performed to clarify the
relationship between GCDC-induced hepatocyte apoptosis and NF-κB
activation.
In summary, GCDC induced apoptosis in rat primary hepatocytes
with a biphasic response. The biphasic response involved an interaction
between the activation NF-κB and the expression of Survivin. The anti-
apoptotic Survivin, regulated by NF-κB, might be a decisive factor of the
biphasic response. NF-κB/Survivin is an essential signaling pathway
that protects hepatocytes from GCDC-induced apoptosis.
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